This content is machine translated Prostate cancer Diagnosis without drama – ESMO 2025 under the banner of differentiated patient management The annual ESMO Congress of the European Society for Medical Oncology, which was held this year in Berlin from October 17 to 21, 2025, offered an impressive variety of topics...…
View Post 4 min This content is machine translated Tuberculosis New standard for MDR-TB therapy The standard treatment for tuberculosis remains 2 months of quadruple therapy with rifampicin, isoniazid, pyrazinamide, and ethambutol, followed by 4 months of therapy with rifampicin and and isoniazid. The average…
View Post 5 min This content is machine translated Systemic lupus erythematosus (SLE) Besides Belimumab, other biologics soon available for the treatment of SLE? The therapeutic options available today allow the choice of an individualized therapeutic strategy. In addition to covventional immunosuppressants, biologics are becoming increasingly important. Belimumab has been approved as an add-on…
View Post 2 min This content is machine translated Thrust-remitting MS An update on basic oral therapy Several encouraging advances have been made in the treatment of relapsing-remitting multiple sclerosis (MS) in recent years. Thus, the first orally administered substance – fingolimod – now also has a…